215 related articles for article (PubMed ID: 16132038)
1. Influence of the cytoplasmic domain of E-cadherin on endogenous N-cadherin expression in malignant melanoma.
Kuphal S; Bosserhoff AK
Oncogene; 2006 Jan; 25(2):248-59. PubMed ID: 16132038
[TBL] [Abstract][Full Text] [Related]
2. H-cadherin expression reduces invasion of malignant melanoma.
Kuphal S; Martyn AC; Pedley J; Crowther LM; Bonazzi VF; Parsons PG; Bosserhoff AK; Hayward NK; Boyle GM
Pigment Cell Melanoma Res; 2009 Jun; 22(3):296-306. PubMed ID: 19368692
[TBL] [Abstract][Full Text] [Related]
3. Expression of Hugl-1 is strongly reduced in malignant melanoma.
Kuphal S; Wallner S; Schimanski CC; Bataille F; Hofer P; Strand S; Strand D; Bosserhoff AK
Oncogene; 2006 Jan; 25(1):103-10. PubMed ID: 16170365
[TBL] [Abstract][Full Text] [Related]
4. Reversal of melanocytic malignancy by keratinocytes is an E-cadherin-mediated process overriding beta-catenin signaling.
Li G; Fukunaga M; Herlyn M
Exp Cell Res; 2004 Jul; 297(1):142-51. PubMed ID: 15194432
[TBL] [Abstract][Full Text] [Related]
5. Tbx3 represses E-cadherin expression and enhances melanoma invasiveness.
Rodriguez M; Aladowicz E; Lanfrancone L; Goding CR
Cancer Res; 2008 Oct; 68(19):7872-81. PubMed ID: 18829543
[TBL] [Abstract][Full Text] [Related]
6. The specific activation of gadd45 following UVB radiation requires the POU family gene product N-oct3 in human melanoma cells.
Lefort K; Rouault JP; Tondereau L; Magaud JP; Doré JF
Oncogene; 2001 Nov; 20(50):7375-85. PubMed ID: 11704867
[TBL] [Abstract][Full Text] [Related]
7. KCl cotransporter-3 down-regulates E-cadherin/beta-catenin complex to promote epithelial-mesenchymal transition.
Hsu YM; Chen YF; Chou CY; Tang MJ; Chen JH; Wilkins RJ; Ellory JC; Shen MR
Cancer Res; 2007 Nov; 67(22):11064-73. PubMed ID: 18006853
[TBL] [Abstract][Full Text] [Related]
8. Functional implication of truncated P-cadherin expression in malignant melanoma.
Bauer R; Bosserhoff AK
Exp Mol Pathol; 2006 Dec; 81(3):224-30. PubMed ID: 16919267
[TBL] [Abstract][Full Text] [Related]
9. Characterization of E-cadherin-dependent and -independent events in a new model of c-Fos-mediated epithelial-mesenchymal transition.
Mejlvang J; Kriajevska M; Berditchevski F; Bronstein I; Lukanidin EM; Pringle JH; Mellon JK; Tulchinsky EM
Exp Cell Res; 2007 Jan; 313(2):380-93. PubMed ID: 17141758
[TBL] [Abstract][Full Text] [Related]
10. E-cadherin suppression accelerates squamous cell carcinoma progression in three-dimensional, human tissue constructs.
Margulis A; Zhang W; Alt-Holland A; Crawford HC; Fusenig NE; Garlick JA
Cancer Res; 2005 Mar; 65(5):1783-91. PubMed ID: 15753375
[TBL] [Abstract][Full Text] [Related]
11. P-cadherin promotes cell-cell adhesion and counteracts invasion in human melanoma.
Van Marck V; Stove C; Van Den Bossche K; Stove V; Paredes J; Vander Haeghen Y; Bracke M
Cancer Res; 2005 Oct; 65(19):8774-83. PubMed ID: 16204047
[TBL] [Abstract][Full Text] [Related]
12. The role of cadherin/catenin complex in malignant melanoma.
Bonitsis N; Batistatou A; Karantima S; Charalabopoulos K
Exp Oncol; 2006 Sep; 28(3):187-93. PubMed ID: 17080010
[TBL] [Abstract][Full Text] [Related]
13. Loss of E-cadherin leads to upregulation of NFkappaB activity in malignant melanoma.
Kuphal S; Poser I; Jobin C; Hellerbrand C; Bosserhoff AK
Oncogene; 2004 Nov; 23(52):8509-19. PubMed ID: 15378016
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
Lim SO; Gu JM; Kim MS; Kim HS; Park YN; Park CK; Cho JW; Park YM; Jung G
Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
[TBL] [Abstract][Full Text] [Related]
15. Cadherin expression in melanocytic naevi and malignant melanomas.
Cowley GP; Smith ME
J Pathol; 1996 Jun; 179(2):183-7. PubMed ID: 8758211
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of COOH-terminal binding protein expression in malignant melanomas leads to induction of MIA expression.
Poser I; Golob M; Weidner M; Buettner R; Bosserhoff AK
Cancer Res; 2002 Oct; 62(20):5962-6. PubMed ID: 12384563
[TBL] [Abstract][Full Text] [Related]
17. Prognostic relevance of P-cadherin expression in melanocytic skin tumours analysed by high-throughput tissue microarrays.
Bauer R; Wild PJ; Meyer S; Bataille F; Pauer A; Klinkhammer-Schalke M; Hofstaedter F; Bosserhoff AK
J Clin Pathol; 2006 Jul; 59(7):699-705. PubMed ID: 16565225
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of cadherins during development and carcinogenesis.
Peinado H; Portillo F; Cano A
Int J Dev Biol; 2004; 48(5-6):365-75. PubMed ID: 15349812
[TBL] [Abstract][Full Text] [Related]
19. S100A4 expression with reduced E-cadherin expression predicts distant metastasis of human malignant melanoma cell lines in the NOD/SCID/gammaCnull (NOG) mouse model.
Ikoma N; Yamazaki H; Abe Y; Oida Y; Ohnishi Y; Suemizu H; Matsumoto H; Matsuyama T; Ohta Y; Ozawa A; Ueyama Y; Nakamura M
Oncol Rep; 2005 Sep; 14(3):633-7. PubMed ID: 16077966
[TBL] [Abstract][Full Text] [Related]
20. Cell adhesion molecule L1 disrupts E-cadherin-containing adherens junctions and increases scattering and motility of MCF7 breast carcinoma cells.
Shtutman M; Levina E; Ohouo P; Baig M; Roninson IB
Cancer Res; 2006 Dec; 66(23):11370-80. PubMed ID: 17145883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
